Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0FN4T
|
|||
| Drug Name |
RM-1929
|
|||
| Indication | Head and neck cancer [ICD-11: 2D42] | Phase 2 | [1], [2] | |
| Company |
Aspyrian Therapeutics San Diego, CA
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
| REF 2 | Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA) | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.